Disease Info Card

Crigler-najjar Syndrome

Information about Crigler-najjar Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Crigler-najjar Syndrome

Most recent studies have shown that Crigler-najjar Syndrome shares some biological mechanisms with brain-injuries, cholestasis, crigler-najjar-syndrome-type-i, crigler-najjar-syndrome-type-ii-(disorder), encephalopathies, gilbert-disease-(disorder), hepatitis, hepatolenticular-degeneration, hyperbilirubinemia, hyperbilirubinemia-hereditary, hyperbilirubinemia-neonatal, icterus, inborn-errors-of-metabolism, jaundice-chronic-idiopathic, kernicterus, liver-diseases, liver-failure, metabolic-diseases, neonatal-jaundice, unconjugated-hyperbilirubinemia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Crigler-najjar Syndrome, and have been seen in publications frequently: Bilirubin Conjugation, Cell Proliferation, Coagulation, Conjugation, Demethylation, Diuresis, Dna Methylation, Excretion, Flight, Hepatocyte Proliferation, Immune Response, Intracellular Transport, Lipid Storage, Liver Development, Pathogenesis, Reverse Transcription, Secretion, Transport, Urea Cycle, Xenobiotic Glucuronidation

Quite a number of genes have been found to play important roles in Crigler-najjar Syndrome, such as ALB, FECH, G6PD, GLB1, IBSP, NT5C1A, NT5C2, OTC, QPCT, SERPINA1, SLC35A2, SLC45A2, UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A6, UGT1A9. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.